Add Company
Join Now

PRECIRIX Revenue and Competitors

License our Company Data API

Brussels,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • PRECIRIX's estimated annual revenue is currently $7M per year.(i)
  • PRECIRIX's estimated revenue per employee is $155,000

Employee Data

  • PRECIRIX has 45 Employees.(i)
  • PRECIRIX grew their employee count by -13% last year.

PRECIRIX's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Science OfficerReveal Email/Phone
3
Discovery ManagerReveal Email/Phone
4
Senior Scientist Protein EngineeringReveal Email/Phone
5
radiochemistry engineerReveal Email/Phone
6
Pre-Clinical Research AssistantReveal Email/Phone
7
ScientistReveal Email/Phone
8
PhD - Scientist Organic / RadiochemistReveal Email/Phone
9
Senior Discovery Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is PRECIRIX?

PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments. The company is advancing its lead product CAM-H2 through a Phase I/II clinical trial targeting HER2-positive tumors, while further progressing and broadening its oncology pipeline. PRECIRIX' technology platform allows for a theranostic approach, using the same molecule for patient selection (imaging) and therapy.

keywords:N/A

N/A

Total Funding

45

Number of Employees

$7M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.7M4529%N/A
#2
$3.7M4610%N/A
#3
$8.8M4721%N/A
#4
$8.1M48-35%N/A
#5
$8.2M4936%N/A